E. Atilla Et Al. , "Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?," INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3, pp.257-264, 2017
Atilla, E. Et Al. 2017. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?. INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3 , 257-264.
Atilla, E., Atilla, P. A., & DEMİRER, T., (2017). Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?. INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3, 257-264.
Atilla, Erden, Pinar Ataca Atilla, And TANER DEMİRER. "Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?," INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3, 257-264, 2017
Atilla, Erden Et Al. "Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?." INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3, pp.257-264, 2017
Atilla, E. Atilla, P. A. And DEMİRER, T. (2017) . "Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?." INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.105, no.3, pp.257-264.
@article{article, author={Erden Atilla Et Al. }, title={Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?}, journal={INTERNATIONAL JOURNAL OF HEMATOLOGY}, year=2017, pages={257-264} }